Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Glicoproteína IIIa")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 170

  • Page / 7
Export

Selection :

  • and

Fine specificity of drug-dependent antibodies reactive with a restricted domain of platelet GPIIIAPETERSON, Julie A; NELSON, Tamara N; KANACK, Adam J et al.Blood. 2008, Vol 111, Num 3, pp 1234-1239, issn 0006-4971, 6 p.Article

Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: Final results of the National Investigators Collaborating on Enoxaparin-3 (nice-3) studyFERGUSON, James J; ANTMAN, Elliott M; BATES, Eric R et al.The American heart journal. 2003, Vol 146, Num 4, pp 628-634, issn 0002-8703, 7 p.Article

Drug-eluting stouts and glycoprotein IIb/IIIa inhibitors: Combination therapy for the futureLEON, Martin B; BAKHAI, Ameet.The American heart journal. 2003, Vol 146, Num 4, pp S13-S17, issn 0002-8703, SUPConference Paper

Association of the platelet glycoprotein receptor IIIa (PIA1/PIA1) genotype with coronary artery disease in ArabsABU-AMERO, Khaled K; WYNGAARD, Carol A; DZIMIRI, Nduna et al.Blood coagulation & fibrinolysis. 2004, Vol 15, Num 1, pp 77-79, issn 0957-5235, 3 p.Article

Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromesSRICHAI, Monvadi B; JABER, Wael A; PRIOR, David L et al.The American heart journal. 2004, Vol 147, Num 1, pp 84-90, issn 0002-8703, 7 p.Article

Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization. CommentaryFURMAN, Mark I; KRUEGER, Lori A; LINDEN, Matthew D et al.Journal of the American College of Cardiology. 2004, Vol 43, Num 12, pp 2319-2328, issn 0735-1097, 10 p.Article

Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)REBEIZ, Abdallah G; JOHANSON, Per; TOPOL, Eric J et al.The American journal of cardiology. 2005, Vol 95, Num 5, pp 611-614, issn 0002-9149, 4 p.Article

PROFOUND THROMBOCYTOPENIA WITH GLYCOPROTEIN IIb/IIIa INHIBITORS PLUS HEPARIN FOR PUMP THROMBUS. Authors' replyBLAIS, Danielle M; SUN, Benjamin; VESCO, Paul et al.The Journal of heart and lung transplantation. 2008, Vol 27, Num 12, pp 1361-1362, issn 1053-2498, 2 p.Article

Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpuraSUKATI, Hosea; WATSON, Henry G; J.URBANIAK, Stanislaw et al.Blood. 2007, Vol 109, Num 10, pp 4528-4538, issn 0006-4971, 11 p.Article

Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the replace-2 trial)CHEW, Derek P; LINCOFF, A. Michael; GURM, Hitinder et al.The American journal of cardiology. 2005, Vol 95, Num 5, pp 581-585, issn 0002-9149, 5 p.Article

Corticotropin-releasing hormone (CRH) in psychiatry: from stress to psychopathologyCLAES, Stephan J.Annals of medicine (Helsinki). 2004, Vol 36, Num 1, pp 50-61, issn 0785-3890, 12 p.Article

Combined effects of mild hypothermia and glycoprotein IIb/IIIa antagonists on platelet-platelet and leukocyte-platelet aggregationFRELINGER, Andrew L; FURMAN, Mark I; BARNARD, Marc R et al.The American journal of cardiology. 2003, Vol 92, Num 9, pp 1099-1101, issn 0002-9149, 3 p.Article

Cooperative effect of GNB3 825C>T and GPIIIa PI(A) polymorphisms in enhanced platelet aggregationFREY, Ulrich H; ARAL, Nese; MÜLLER, Norbert et al.Thrombosis research. 2003, Vol 109, Num 5-6, pp 279-286, issn 0049-3848, 8 p.Article

Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stentingCHAN, Albert W; YADAV, Jay S; BHATT, Deepak L et al.The American journal of cardiology. 2005, Vol 95, Num 6, pp 791-795, issn 0002-9149, 5 p.Article

The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors : The Do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trialBERGER, Peter B; BEST, Patricia J. M; TOPOL, Eric J et al.The American heart journal. 2005, Vol 149, Num 5, pp 869-875, issn 0002-8703, 7 p.Article

Infarct angioplasty: beyond stents and glycoprotein IIb/IIIa inhibitorsDIXON, S. R.Heart. Supplement. 2005, Vol 91, Num 3, pp iii2-iii6Article

Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary interventionDAY, J. R. S; MALIK, I. S; WEERASINGHE, A et al.Heart (London 1996). 2004, Vol 90, Num 7, pp 794-799, issn 1355-6037, 6 p.Article

Optimizing glycoprotein IIb/IIIa receptor antagonist use for the non-ST-segment elevation acute coronary syndromes: Risk stratification and therapeutic interventionJANUZZI, James L; CANNON, Christopher P; THEROUX, Pierre et al.The American heart journal. 2003, Vol 146, Num 5, pp 764-774, issn 0002-8703, 11 p.Article

Ultrasonic atomization and subsequent desolvation for monoclonal antibody (mAb) to the glycoprotein (GP) IIIa receptor into drug eluting stentWANG, G. X; LUO, L. L; YIN, T. Y et al.Journal of microencapsulation. 2010, Vol 27, Num 2, pp 105-114, issn 0265-2048, 10 p.Article

Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signalingGOTO, Shinya; TAMURA, Noriko; ISHIDA, Hideyuki et al.Journal of the American College of Cardiology. 2006, Vol 47, Num 1, pp 155-162, issn 0735-1097, 8 p.Article

Thrombopénies néonatales dues à un allo-anticorps anti-HPA-5b : à propos de deux cas observés en Tunisie = HPA-5b neonatal allo-immune thrombocytopenia: two cases described in TunisiaSKOURI, H; SOUA, H; SEKET, B et al.Archives de pédiatrie (Paris). 2003, Vol 10, Num 10, pp 887-890, issn 0929-693X, 4 p.Article

Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitorsASTER, Richard H.Chest. 2005, Vol 127, Num 2, pp 53S-59S, issn 0012-3692, SUPArticle

Effect of glycoprotein IIIa PIA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smokingLOPES, Neuza H. M; PEREIRA, Alexandre C; HUEB, Whady et al.The American journal of cardiology. 2004, Vol 93, Num 12, pp 1469-1472, issn 0002-9149, 4 p.Article

Association between the PlA platelet glycoprotein GPIIIa polymorphism and extent of coronary artery diseaseGRUCHAŁA, Marcin; CIECWIERZ, Dariusz; LIMON, Janusz et al.International journal of cardiology. 2003, Vol 88, Num 2-3, pp 229-237, issn 0167-5273, 9 p.Article

Frequency and management of thrombocytopenia with the glycoprotein IIb/IIIa receptor antagonistsHUXTABLE, Lindsay M; TAFRESHI, Mohammad J; RAKKAR, Amol N. S et al.The American journal of cardiology. 2006, Vol 97, Num 3, pp 426-429, issn 0002-9149, 4 p.Article

  • Page / 7